PT-141 (Bremelanotide) Prescribed Online to Maryland Residents
PT-141 (Bremelanotide) is a melanocortin receptor agonist that enhances sexual desire and arousal through the central nervous system — not the vascular system. It is the first non-hormonal treatment for hypoactive sexual desire disorder approved by the FDA.
What Is PT-141 (Bremelanotide)?
PT-141 (Bremelanotide) is a melanocortin receptor agonist that enhances sexual desire and arousal through the central nervous system — not the vascular system. It is the first non-hormonal treatment for hypoactive sexual desire disorder approved by the FDA.
Benefits of PT-141 (Bremelanotide)
Works through the brain to enhance desire and arousal
Effective for both men and women
Addresses root causes of low libido rather than just physical response
FDA-approved active ingredient (Vyleesi for women)
Unique central mechanism distinct from PDE5 inhibitors
Maryland bridges the nation's capital with the Chesapeake Bay's natural beauty. OmniRx Health serves this diverse state—from the federal workers of Montgomery County to the waterfront communities of the Eastern Shore, the professionals of Baltimore's Inner Harbor to the rural areas of Western Maryland. Our telehealth platform is perfect for busy Marylanders who want world-class care without the notorious DC-area traffic.
Getting PT-141 (Bremelanotide) Prescribed in Maryland
Licensed in MD
Our providers are licensed by the Maryland Board of Physicians to deliver telehealth services throughout the state.
Pharmacy Delivery
Maryland's extensive pharmacy network in Baltimore, DC suburbs, and throughout the state ensures rapid prescription access and delivery.
Maryland has comprehensive telehealth laws that balance innovation with patient protection, supporting virtual care across the state.
Frequently Asked Questions About PT-141 (Bremelanotide)
Common questions from Maryland residents about PT-141 (Bremelanotide) treatment
Explore Related Sexual Wellness Options
Find the right treatment, in the right state, for you.